Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Assets (2016 - 2025)

Mimedx (MDXG) has disclosed Assets for 15 consecutive years, with $342.7 million as the latest value for Q4 2025.

  • Quarterly Assets rose 29.83% to $342.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $342.7 million through Dec 2025, up 29.83% year-over-year, with the annual reading at $342.7 million for FY2025, 29.83% up from the prior year.
  • Assets hit $342.7 million in Q4 2025 for Mimedx, up from $319.0 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $342.7 million in Q4 2025 to a low of $168.2 million in Q1 2023.
  • Historically, Assets has averaged $219.5 million across 5 years, with a median of $189.9 million in 2021.
  • Biggest five-year swings in Assets: fell 15.38% in 2021 and later soared 39.44% in 2023.
  • Year by year, Assets stood at $187.9 million in 2021, then dropped by 8.78% to $171.4 million in 2022, then soared by 39.44% to $239.0 million in 2023, then rose by 10.4% to $263.9 million in 2024, then rose by 29.83% to $342.7 million in 2025.
  • Business Quant data shows Assets for MDXG at $342.7 million in Q4 2025, $319.0 million in Q3 2025, and $291.1 million in Q2 2025.